Molecular Formula | C9H7NO2 |
Molar Mass | 161.16 |
Density | 1.2480 (rough estimate) |
Melting Point | 270-275 °C |
Boling Point | 287.44°C (rough estimate) |
Flash Point | 234.3°C |
Solubility | DMSO: >36mg/mL |
Vapor Presure | 3.18E-09mmHg at 25°C |
Appearance | solid |
Color | off-white |
pKa | 8.52±0.20(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
Refractive Index | 1.5050 (estimate) |
In vitro study | 1,5-isoquinolinediol leads to an increase up to 8-fold in the absolute frequency of gene targeting in the correction of the mutation at the stable integrated HSV tk gene. 1,5-Isoquinolinediol is a potent PARP antagonist and decreases cleaved PARP in diabetic retina. 1,5-Isoquinolinediol (500 μM H2O2; 24 hours) attenuates H2O2-induced upregulation of cleaved PARP-1 expression in retinal Muller cells. 1,5-Isoquinolinediol attenuates diabetes-induced upregulation of retinal nitrated protein expression. 1,5-Isoquinolinediol attenuates diabetes-induced activation of NADPH oxidase in the retina. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S37/39 - Wear suitable gloves and eye/face protection |
WGK Germany | 3 |
HS Code | 29337900 |
Biological activity | 1,5-Isoquinolinediol is an effective PARP inhibitor with an IC50 value of 0.18-0.37 µM. 1,5-Isoquinolinediol attenuates diabetic-induced oxidative stress induced by retinal NADPH oxidase. |
target | PARP 0.18-0.37 μM (IC 50 ) |
in vitro research | 1,5-isoquinolinediol heads to an increase up to 8-fold in the absolute frequency of gene targeting in the correction of the mutation at the stable integrated HSV tk gene. 1,5-isoquinolinediol is a potent antagonist and decreases cleaved PARP in diabetic retina. 1,5-Isoquinolinediol (500 μM H2O2; 24 hours) attenuates H2O2-induced upregulation of cleaved PARP-1 expression in retinal Muller cells. 1,5-Isoquinolinediol attenuates diabetes-induced upregulation of retinal nitrated protein expression. 1,5-Isoquinolinediol attenuates diabetes-induced activation of NADPH oxidase in the retina. |